English Text

Direct Sequencing (Sanger Sequencing) Method
Next Generation Sequencing
Clinical Exome Sequencing
Targeted Exome Sequencing
Chromosomal Microarray Analysis
Multiplex Ligation Dependent Probe Amplification
High Resolution Melting - HRM Analysis
Fragment analysis
Other Methods
Next Generation Sequencing
Services • Methods
Next-Generation Sequencing - (NGS)
Massive simultaneous parallel sequencing of plenty of genes, all genes in the individual (exome) or whole genome (whole DNA, which includes all genes plus the noncoding DNA sequences).
Depending on the specifics and scope of the analysis Laboratory of Genomic Diagnostics offers two platforms of NGS sequencing with two different mechanisms of sequencing – Miseq (Illumina) and Ion Torrent PGM (Life Technologies).
- Test 2 - Hereditary Breast and Ovarian Cancer (HBOC)
- Test 3 - Hereditary Breast and Ovarian Cancer (HBOC)
- Test 6 - Hereditary Breast and Ovarian Cancer (HBOC)
- Test 7 - Hereditary Breast and Ovarian Cancer (HBOC)
- Test 9 - Hereditary Nonpolyposis Colorectal Cancer HNPCC (Lynch syndrome)
- Test 14 - Hereditary Nonpolyposis Colorectal Cancer HNPCC (Lynch syndrome)
- Test 15 - Hereditary Gastrointestinal Tumors
- Test 27 - Familial Prostate Cancer
- Test 28 - Hematologic Oncologic Diseases
- Test 29 - Hereditary Paraganglioma - Pheochromocytoma / PGL/PCC syndrome/
- Test 30 - Hereditary syndromes associated with tumors of CNS, PNS
- Test 31 - RASopathies, Genetic syndroms, resulting from mutations in genes coding components or regulators of Ras/MAPK pathway
- Test 32 - Medulloblastoma
- Test 33 - Sarcoma
- Test 34 - Hereditary Neuroblastoma
- Test 47 - Epileptic encephalopathies
- Test 48 - Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)
- Test 49 - Epilepsy and epileptic syndromes - extended panel
- Test 50 - Мigraine
- Test 51 - Syndromic intellectual disability
- Test 52 - Autism
- Test 54 - Hereditary spastic paraplegia
- Test 56 - Hereditary neuropathies
- Test 57 - Hereditary cerebellar ataxia
- Test 58 - Cerebellar hypoplasia
- Test 59 - Arthrogryposis
- Test 60 - Neuromuscular diseases
- Test 62 - Alzheimer's disease
- Test 63 - Parkinson's disease
- Test 64 - Dementia
- Test 65 - Frontotemporal degeneration
- Test 66 - Amyotrophic lateral sclerosis
- Test 68 - Motor disorders
- Test 69 - Childhood onset leukodystrophy
- Test 70 - Leukodystrophy with brain calcifications
- Test 71 - Late-onset leukodystrophy
- Test 72 - Congenital hypotension
- Test 75 - Macular degeneration (including Stargardt disease, associated with age-related macular degeneration and others)
- Test 77 - Macular degeneration (including Stargardt disease, associated with age-related macular degeneration and others)
- Test 81 - Glaucoma
- Test 85 - Cone-rod retinal degeneration
- Test 88 - Leber congenital amaurosis
- Test 98 - Retinal pigment degeneration (Retinitis pigmentosa)
- Test 99 - Retinal degeneration Usher syndrome type 2
- Test 102 - Bardet-Biedl syndrome
- Test 103 - Congenital stationary night blindness
- Test 107 - Cataract
- Test 111 - Syndromic and non-syndromic hearing loss
- Test 114 - Cortico-resistant nephrotic syndrome
- Test 116 - Congenital anomalies of the urinary system
- Test 119 - Ciliopathies
- Test 120 - Endocrine diseases
- Test 121 - Congenital hypopituitarism
- Test 126 - Isolated Growth Hormone Deficiency
- Test 130 - Maturity-onset diabetes of youth (MODY)
- Test 131 - Cardiovascular diseases
- Test 133 - Мitochondrial diseases
- Test 134 - Connective tissue diseases
- Test 135 - Marfan Syndrome and Marfan-Like Disorders
- Test 136 - Skeletal dysplasias
- Test 137 - Liver diseases
- Test 138 - Immune diseases
- Test 139 - Hematological diseases
- Test 140 - Syndromic and nonsyndromic diseases with dermatological symptoms
- Test 141 - Reproductive panel - women
- Test 142 - Reproductive panel - men
- Test 143 - Metabolic diseases
- Test 178 - Analysis of extended panel of genes for Family Oncology Diseases and Interpretation
- Test 179 - Analysis of gene pannel associated with targeted therapy in solid tumors and interpretation
- Test 180 - Whole exome sequencing (WES) and interpretation of clinical exome
- Test 181 - Whole exome sequencing (WES), analysis and interpretation not included
- Test 210 - Analysis of clinical exome, confirmation and interpretation, with reagents provided by the Ministry of Health